Literature DB >> 28755533

Wasting away: How to treat cachexia and muscle wasting in chronic disease?

Stephan von Haehling1,2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28755533      PMCID： PMC5698575          DOI： 10.1111/bcp.13387

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  26 in total

1.  The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.

Authors:  S Bhasin; T W Storer; N Berman; C Callegari; B Clevenger; J Phillips; T J Bunnell; R Tricker; A Shirazi; R Casaburi
Journal:  N Engl J Med       Date:  1996-07-04       Impact factor: 91.245

Review 2.  Cancer cachexia, recent advances, and future directions.

Authors:  Marie-France Penet; Zaver M Bhujwalla
Journal:  Cancer J       Date:  2015 Mar-Apr       Impact factor: 3.360

Review 3.  The Evolving Approach to Management of Cancer Cachexia.

Authors:  Rony Dev; Angelique Wong; David Hui; Eduardo Bruera
Journal:  Oncology (Williston Park)       Date:  2017-01-15       Impact factor: 2.990

4.  Cachexia: a new definition.

Authors:  William J Evans; John E Morley; Josep Argilés; Connie Bales; Vickie Baracos; Denis Guttridge; Aminah Jatoi; Kamyar Kalantar-Zadeh; Herbert Lochs; Giovanni Mantovani; Daniel Marks; William E Mitch; Maurizio Muscaritoli; Armine Najand; Piotr Ponikowski; Filippo Rossi Fanelli; Morrie Schambelan; Annemie Schols; Michael Schuster; David Thomas; Robert Wolfe; Stefan D Anker
Journal:  Clin Nutr       Date:  2008-08-21       Impact factor: 7.324

5.  Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials.

Authors:  Jennifer S Temel; Amy P Abernethy; David C Currow; John Friend; Elizabeth M Duus; Ying Yan; Kenneth C Fearon
Journal:  Lancet Oncol       Date:  2016-02-20       Impact factor: 41.316

6.  Association of estimated glomerular filtration rate with all-cause and cardiovascular mortality: the role of malnutrition-inflammation-cachexia syndrome.

Authors:  Shuo-Ming Ou; Yung-Tai Chen; Szu-Chun Hung; Chia-Jen Shih; Chi-Hung Lin; Chih-Kang Chiang; Der-Cherng Tarng
Journal:  J Cachexia Sarcopenia Muscle       Date:  2016-01-05       Impact factor: 12.910

7.  Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016.

Authors:  Stephan von Haehling; Markus S Anker; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2016-11-02       Impact factor: 12.910

8.  Highlights from the 7th Cachexia Conference: muscle wasting pathophysiological detection and novel treatment strategies.

Authors:  Nicole Ebner; Lisa Steinbeck; Wolfram Doehner; Stefan D Anker; Stephan von Haehling
Journal:  J Cachexia Sarcopenia Muscle       Date:  2014-03-05       Impact factor: 12.910

Review 9.  Cachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspective.

Authors:  Karin J C Sanders; Anita E M Kneppers; Coby van de Bool; Ramon C J Langen; Annemie M W J Schols
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-09-07       Impact factor: 12.910

10.  SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes.

Authors:  Theodore K Malmstrom; Douglas K Miller; Eleanor M Simonsick; Luigi Ferrucci; John E Morley
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-07-07       Impact factor: 12.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.